These data indicate that BCP exerts a protective effect against ischemic stroke-induced inflammatory injury by regulating the HMGB1/TLR4/RAGE signaling pathway, which provides new insights into the mechanisms of this therapeutic candidate for the treatment of ischemic stroke. Here, TLR4 is linked to ischemic stroke.